Literature DB >> 30852607

Ki-67 and p16 Immunostaining Differentiates Pagetoid Bowen Disease From "Microclonal" Seborrheic Keratosis.

Eman Bahrani1, Panitta Sitthinamsuwan2, Timothy H McCalmont1,3, Laura B Pincus1,3.   

Abstract

OBJECTIVES: We observed keratoses with "clonal" nests present as numerous tiny collections, in which cells in "pagetoid" array are found, a configuration we termed microclonal seborrheic keratosis (MSK). To better distinguish MSK from pagetoid Bowen disease (PBD), we investigated use of immunohistochemical staining.
METHODS: Biopsy specimens of 26 MSKs, 17 PBDs, and 11 borderline cases were reviewed for histopathology and stained with p53, Ki-67, and p16.
RESULTS: High expression of Ki-67 and p16 was observed in 12 (80%) of 15 PBDs and in one (4%) of 23 MSKs. Low expression of p16 and high expression of Ki-67 were observed in 16 (70%) of 23 MSKs and in two (13%) of 15 PBDs. Expression of p16 was elevated in 12 (80%) of 15 PBDs and in three (13%) of 23 MSKs (P < .0001).
CONCLUSIONS: We describe a "microclonal" variant of seborrheic keratosis with morphology sometimes challenging to distinguish from PBD. High expression of p16 and Ki-67 or p16 alone favors the diagnosis of PBD over MSK. © American Society for Clinical Pathology, 2019. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  Bowen disease; Clonal seborrheic keratosis; Immunohistochemistry; p53

Mesh:

Substances:

Year:  2019        PMID: 30852607     DOI: 10.1093/ajcp/aqz001

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  2 in total

1.  Variability in the Histopathological Diagnosis of Non-Melanocytic Lesions Excised to Exclude Melanoma.

Authors:  Ian Katz; Tony Azzi; Alister Lilleyman; Blake O'Brien; Brian Schapiro; Curtis Thompson; Tarl Prow
Journal:  Dermatol Pract Concept       Date:  2021-10-01

Review 2.  Recent advances in managing and understanding seborrheic keratosis.

Authors:  Uwe Wollina
Journal:  F1000Res       Date:  2019-08-28
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.